Comparison of lesion segmentation performance in diffusion-weighted imaging and apparent diffusion coefficient images of stroke by artificial neural networks.

Journal: PloS one
Published Date:

Abstract

Stroke is the second leading cause of death, accounting for 11% of deaths worldwide. Comparing diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) images is important for stroke diagnosis, but most studies have focused on lesion segmentation using DWI. In this study, we compared the performance of lesion segmentation using DWI and ADC images. This study was conducted using a retrospective design A dataset was constructed using data from 360 patients with ischemic stroke collected from Gachon University Gil Medical Center. Artificial intelligence models, U-Net, and a fully connected network (FCN), were used to train each type of image data. The performance of the models was validated using five-fold cross-validation and evaluated based on metrics such as the dice similarity coefficient (DSC), accuracy, precision, and recall. As a result, the U-Net model demonstrated a DSC of 92.13 ± 0.91% on DWI and 83.68 ± 10% on ADC, whereas the FCN model exhibited a DSC of 82.86 ± 1.56% on DWI and 79.26 ± 1.19% on ADC. These metrics indicated that the trained models were suitable for lesion segmentation. A comparative analysis of DWI and ADC based on the trained models revealed similar results across the models, suggesting that lesion segmentation on ADC images is appropriate. For future research, the accuracy of ADC images is recommended to be imporved by utilizing images with different b-values, or training models with datasets that combe DWI and ADC images based on enhanced data.

Authors

  • Seok Jin Bang
    Medical Devices R&D Center, Gachon University Gil Medical Center, Incheon, Republic of Korea.
  • Yong-Tae Kim
    Department of Biomedical Engineering, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Young Jae Kim
    Department of Biomedical Engineering, College of Medicine, Gachon University, Gyeonggi-do, Republic of Korea.
  • Kwang Gi Kim
    Department of Biomedical Engineering Branch, National Cancer Center, Gyeonggi-do, South Korea.